PHARMAGEN, INC. Operating Income
PHARMAGEN, INC. reported Operating Income of -$410.52 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2014-05-15
- PHARMAGEN, INC. operating income (loss) for the quarter ending 2014-03-31 was -$410.52K.
- PHARMAGEN, INC. operating income (loss) for the quarter ending 2013-12-31 was -$1.97M.
- PHARMAGEN, INC. operating income (loss) for the quarter ending 2013-09-30 was -$970.01K.
- PHARMAGEN, INC. operating income (loss) for the quarter ending 2013-06-30 was -$342.38K.
- PHARMAGEN, INC. operating income (loss) for fiscal 2013 was -$3.61M.
- PHARMAGEN, INC. operating income (loss) for fiscal 2012 was -$2.10M.
- PHARMAGEN, INC. operating income (loss) for fiscal 2011 was -$282.54K.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 27 month | Operating Income (Loss) 30 month |
|---|---|---|---|---|---|---|---|
| 2014-03-31 | -$410.52K 10-Q · filed 2014-05-15 | -$2.38M derived: sum of 2 quarters · filed 2014-05-15 | -$3.35M derived: sum of 3 quarters · filed 2014-05-15 | -$3.69M derived: sum of 4 quarters · filed 2014-05-15 | |||
| 2013-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$2.94M derived: sum of 2 quarters · filed 2014-03-31 | -$3.28M derived: sum of 3 quarters · filed 2014-03-31 | -$3.61M 10-K · filed 2014-03-31 | |||
| 2013-09-30 | -$970.01K 10-Q · filed 2013-11-14 | -$1.31M derived: sum of 2 quarters · filed 2013-11-14 | -$1.64M 10-Q · filed 2013-11-14 | -$2.47M derived: sum of 4 quarters · filed 2014-05-15 | |||
| 2013-06-30 | -$342.38K 10-Q · filed 2013-08-14 | -$669.89K 10-Q · filed 2013-08-14 | -$1.50M derived: sum of 3 quarters · filed 2014-05-15 | -$2.08M derived: sum of 4 quarters · filed 2014-05-15 | |||
| 2013-03-31 | -$327.51K 10-Q · filed 2014-05-15 | -$655.67K 10-Q · filed 2013-05-15 | -$1.16M derived: sum of 2 quarters · filed 2014-05-15 | -$1.73M derived: sum of 3 quarters · filed 2014-05-15 | -$2.20M derived: sum of 4 quarters · filed 2014-05-15 | ||
| 2012-12-31 | -$832.47K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$1.41M derived: sum of 2 quarters · filed 2014-03-31 | -$1.88M derived: sum of 3 quarters · filed 2014-03-31 | -$2.10M 10-K · filed 2014-03-31 | |||
| 2012-09-30 | -$574.00K 10-Q · filed 2013-11-14 | -$1.04M derived: sum of 2 quarters · filed 2013-11-14 | -$1.26M 10-Q · filed 2013-11-14 | -$1.28M derived: sum of 4 quarters · filed 2013-11-14 | |||
| 2012-06-30 | -$470.05K 10-Q · filed 2013-08-14 | -$689.78K 10-Q · filed 2013-08-14 | -$709.99K derived: sum of 3 quarters · filed 2013-08-14 | -$868.56K derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-03-31 | -$219.73K 10-Q · filed 2013-05-15 | -$239.94K derived: sum of 2 quarters · filed 2013-05-15 | -$398.51K derived: sum of 3 quarters · filed 2013-05-15 | -$508.48K derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2011-12-31 | -$20.21K 10-Q · filed 2012-02-13 | -$40.44K 10-Q · filed 2012-02-13 | -$288.75K derived: sum of 3 quarters · filed 2012-11-14 | -$282.54K 10-K · filed 2013-04-01 | -$230.38K 10-Q · filed 2012-02-13 | ||
| 2011-09-30 | -$158.57K 10-Q · filed 2012-11-14 | -$20.23K 10-Q · filed 2011-11-14 | -$268.55K derived: sum of 2 quarters · filed 2012-11-14 | -$294.00K 10-Q · filed 2012-11-14 | -$311.38K derived: sum of 4 quarters · filed 2012-11-14 | -$210.18K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$109.97K 10-Q/A · filed 2012-09-14 | -$135.43K 10-Q/A · filed 2012-09-14 | -$152.81K derived: sum of 3 quarters · filed 2012-09-14 | -$171.23K derived: sum of 4 quarters · filed 2012-09-14 | |||
| 2011-03-31 | -$25.45K 10-Q · filed 2012-06-11 | -$42.83K derived: sum of 2 quarters · filed 2012-06-11 | -$61.26K derived: sum of 3 quarters · filed 2012-06-11 | ||||
| 2010-12-31 | -$17.38K 10-Q · filed 2012-02-13 | -$35.80K 10-Q · filed 2012-02-13 | |||||
| 2010-09-30 | -$18.42K 10-Q · filed 2011-11-14 |